Two to Three Cups of Coffee Daily Linked to 35% Lower Dementia Risk in Major Study
A 43-year study of 131,000+ adults found moderate caffeine intake cuts dementia risk by 35% — but more isn't better.
Summary
A large long-term study following over 131,000 healthcare professionals for up to 43 years found that drinking two to three cups of caffeinated coffee or tea daily was linked to a 35% lower risk of developing dementia, particularly in adults under 75. The optimal caffeine dose appears to be around 250–300mg per day. Beyond that threshold, no additional brain protection was observed. Researchers identified several biological mechanisms: caffeine blocks adenosine, which helps maintain dopamine and acetylcholine activity that naturally declines with age. It may also reduce neuroinflammation and amyloid plaque buildup associated with Alzheimer's disease. Notably, people who drank more decaf showed faster memory decline, likely because switching to decaf often signals underlying health issues already linked to cognitive decline.
Detailed Summary
Dementia affects millions of aging adults worldwide, and identifying modifiable lifestyle factors that reduce risk is a major priority in longevity research. A newly published large-scale study offers compelling evidence that a habit many people already have — drinking coffee — may meaningfully protect the aging brain when consumed in moderate amounts.
The study tracked 131,821 nurses and healthcare professionals for up to 43 years, starting when participants were in their early 40s. Over that period, roughly 8% developed dementia. Those who regularly consumed 250–300mg of caffeine per day — equivalent to about two to three cups of coffee — showed a 35% lower dementia risk compared to lower consumers. This protective effect was strongest in adults aged 75 and younger, suggesting earlier and sustained intake may matter most.
Researchers identified several plausible biological mechanisms. Caffeine blocks adenosine receptors, helping sustain the activity of neurotransmitters like dopamine and acetylcholine, both of which decline in Alzheimer's disease. Regular moderate coffee drinkers without dementia also showed lower levels of amyloid plaques — toxic protein aggregates central to Alzheimer's pathology. Anti-inflammatory effects and improved blood sugar metabolism may further contribute to caffeine's neuroprotective profile. Tea drinkers also benefited, with one to two cups daily showing the strongest protective association.
An unexpected finding involved decaffeinated coffee: higher decaf consumption correlated with faster memory decline. Researchers believe this reflects reverse causation — people often switch to decaf due to sleep disruption, hypertension, or cardiac arrhythmias, all conditions independently tied to cognitive decline.
Importantly, more caffeine was not better. Protection plateaued at moderate intake, and excess consumption may introduce other health risks. The study is observational, so causation cannot be confirmed, and confounders like smoking and alcohol use were noted among heavier coffee drinkers. Nonetheless, the scale and duration of this dataset make it among the strongest evidence yet for coffee's role in brain longevity.
Key Findings
- Drinking 2–3 cups of coffee daily linked to 35% lower dementia risk in adults under 75
- Optimal caffeine dose is 250–300mg/day; exceeding this threshold provides no additional brain protection
- Caffeine may reduce amyloid plaque buildup and sustain dopamine and acetylcholine activity in aging brains
- 1–2 cups of tea daily also associated with strong dementia protection in the same cohort
- Higher decaf consumption correlated with faster memory decline, likely due to reverse causation
Methodology
This is a research summary reporting on a large prospective cohort study of 131,821 participants followed for up to 43 years, published via The Conversation and aggregated by ScienceDaily. The evidence basis is observational, meaning causation cannot be established, but the study's scale, duration, and biological plausibility strengthen its credibility considerably.
Study Limitations
As an observational study, this research cannot prove that coffee directly causes reduced dementia risk — confounding variables remain a concern. The cohort was composed largely of healthcare professionals, which may limit generalizability to broader populations. Primary source publication details and peer-review status should be verified before drawing firm clinical conclusions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.